Competitive Benchmarking of Key Opinion Leader Relationship Management by Leading Pharmaceutical and Biotech Companies in the United States
NEW PROGRAM
This new study is a comprehensive look at how leading pharmaceutical and biotech companies manage their key opinion leader (KOL) relationships. The study includes the following:
 | Description of how various internal constituencies (sales reps, medical liaisons, clinical research associates, etc.) interact with KOLs | ||||||
| Typical perks offered to KOLS
| ||||||
| Trends in the relationship model, including impact of PhRMA guidelines and use of personnel beyond medical liaisons to interact with these individuals | ||||||
| CRM software systems used with KOLs | ||||||
| Key metrics utilized to evaluate KOL effectiveness | ||||||
| Use of social influencing mapping to guide KOL tactical planning | ||||||
| Honoraria levels for KOLs
|
* Save 5% -- Mention "PharmCast.com" when purchase.
To receive more information about the study, including a list of companies analyzed and sample pages, click on the "Request for Info" link.
 |
| [
Outsourcing Guide
] [
Cont. Education
] [
Software/Reports
] [
Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ] [ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ] [ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ] [ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ] [ Site Map ] |